Skip to main content
Erschienen in: International Urology and Nephrology 6/2012

01.12.2012 | Nephrology - Original Paper

Presence of glucose in dialyzing fluid and synthesis of selected lipoxygenase-derived eicosanoids during hemodialysis

verfasst von: Barbara Dołęgowska, Wojciech Błogowski, Joanna Stępniewska, Krzysztof Safranow, Katarzyna Jakubowska, Maria Olszewska

Erschienen in: International Urology and Nephrology | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Active metabolites of arachidonic acid (AA), eicosanoids, are exerting a significant influence on renal homeostasis. In our recent paper, we demonstrated that high levels of lipoxygenase (LOX)-derived AA metabolites, hydroxyeicosatetraenoic acids (HETEs), unfavorably influence post-transplant function of kidney allografts. Hence, in this study, we wanted (1) to analyze 5-, 12- and 15-HETE levels in non-diabetic chronic kidney disease (CKD) patients, already undergoing regular hemodialysis treatment, and determine factors that may influence these eicosanoids’ generation, as well as, (2) to verify whether application of glucose-containing, instead of glucose-free, dialyzing fluids may be beneficial for the limitation of 5-, 12- and 15-HETE synthesis during a single hemodialysis session.

Methods

Twenty-four healthy individuals and 50 CKD patients undergoing regular hemodialysis treatment were included in the study. CKD patients were divided into two subgroups depending on presence/absence of glucose in dialyzing fluid. LOX-derived HETEs were measured using liquid chromatography.

Results

Results demonstrated higher levels of examined eicosanoids in CKD patients (P < 0.05 for all). Older age and higher C-reactive protein levels were associated with HETEs concentrations. Presence of glucose in dialyzing fluid significantly diminished the increase in 5- and 12-HETE synthesis (411.24% vs. 107.29%, P < 0.006; 301.70% vs. 98.21%, P < 0.0008, respectively), however, it did not influence 15-HETE generation (156.98% vs. 135.24%, P = 0.26).

Conclusions

Non-diabetic CKD patients have higher levels of LOX-derived HETEs, which are associated mainly with age and intensified inflammatory process. The presence of glucose in the dialysate is associated with a reduced synthesis of selected LOX-derived HETEs in these patients; hence, we speculate that the application of such a simple hemodialysis fluid modification may have a favorable influence on post-transplant outcomes.
Literatur
1.
Zurück zum Zitat Remport A, Keszei A, Vamos EP et al (2011) Association of pre-transplant dialysis duration with outcome in kidney transplant recipients: a prevalent cohort study. Int Urol Nephrol 43:215–224PubMedCrossRef Remport A, Keszei A, Vamos EP et al (2011) Association of pre-transplant dialysis duration with outcome in kidney transplant recipients: a prevalent cohort study. Int Urol Nephrol 43:215–224PubMedCrossRef
2.
Zurück zum Zitat Chung AW, Yang HH, Kim JM et al (2009) Upregulation of matrix metalloproteinase-2 in the arterial vasculature contributes to stiffening and vasomotor dysfunction in patients with chronic kidney disease. Circulation 120:792–801PubMedCrossRef Chung AW, Yang HH, Kim JM et al (2009) Upregulation of matrix metalloproteinase-2 in the arterial vasculature contributes to stiffening and vasomotor dysfunction in patients with chronic kidney disease. Circulation 120:792–801PubMedCrossRef
3.
Zurück zum Zitat Rysz J, Banach M, Stolarek RA et al (2011) Serum metalloproteinases MMP-2, MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in patients on hemodialysis. Int Urol Nephrol 43:491–498PubMedCrossRef Rysz J, Banach M, Stolarek RA et al (2011) Serum metalloproteinases MMP-2, MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in patients on hemodialysis. Int Urol Nephrol 43:491–498PubMedCrossRef
4.
Zurück zum Zitat Granata S, Zaza G, Simone S et al (2009) Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease. BMC Genomics 10:388PubMedCrossRef Granata S, Zaza G, Simone S et al (2009) Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease. BMC Genomics 10:388PubMedCrossRef
5.
Zurück zum Zitat Zaza G, Pontrelli P, Pertosa G et al (2008) Dialysis-related systemic microinflammation is associated with specific genomic patterns. Nephrol Dial Transplant 23:1673–1681PubMedCrossRef Zaza G, Pontrelli P, Pertosa G et al (2008) Dialysis-related systemic microinflammation is associated with specific genomic patterns. Nephrol Dial Transplant 23:1673–1681PubMedCrossRef
6.
Zurück zum Zitat Taccone-Gallucci M, Manca-di-Villahermosa S, Battistini L et al (2006) N-3 PUFAs reduce oxidative stress in ESRD patients on maintenance HD by inhibiting 5-lipoxygenase activity. Kidney Int 69:1450–1454PubMed Taccone-Gallucci M, Manca-di-Villahermosa S, Battistini L et al (2006) N-3 PUFAs reduce oxidative stress in ESRD patients on maintenance HD by inhibiting 5-lipoxygenase activity. Kidney Int 69:1450–1454PubMed
7.
Zurück zum Zitat Cristol JP, Maggi MF, Bosc JY et al (1997) Oxidative stress and chronic renal insufficiency: what can be a prophylactic approach? C R Seances Soc Biol Fil 191:603–616PubMed Cristol JP, Maggi MF, Bosc JY et al (1997) Oxidative stress and chronic renal insufficiency: what can be a prophylactic approach? C R Seances Soc Biol Fil 191:603–616PubMed
8.
Zurück zum Zitat Dołęgowska B, Błogowski W, Safranow K, Domanski L, Jakubowska K, Olszewska M (2010) Lipoxygenase-derived hydroxyeicosatetraenoic acids—novel perioperative markers of early post-transplant allograft function? Nephrol Dial Transplant 25:4061–4067PubMedCrossRef Dołęgowska B, Błogowski W, Safranow K, Domanski L, Jakubowska K, Olszewska M (2010) Lipoxygenase-derived hydroxyeicosatetraenoic acids—novel perioperative markers of early post-transplant allograft function? Nephrol Dial Transplant 25:4061–4067PubMedCrossRef
9.
Zurück zum Zitat Dolegowska B, Stepniewska J, Ciechanowski K et al (2007) Does glucose in dialysis fluid protect erythrocytes in patients with chronic renal failure? Blood Purif 25:422–429PubMedCrossRef Dolegowska B, Stepniewska J, Ciechanowski K et al (2007) Does glucose in dialysis fluid protect erythrocytes in patients with chronic renal failure? Blood Purif 25:422–429PubMedCrossRef
10.
Zurück zum Zitat Dolegowska B, Blogowski W, Chlubek D (2006) The effect in vitro of glucose on erythrocyte resistance to hemolysis. Ann Acad Med Stettin 52:25–28 Dolegowska B, Blogowski W, Chlubek D (2006) The effect in vitro of glucose on erythrocyte resistance to hemolysis. Ann Acad Med Stettin 52:25–28
11.
Zurück zum Zitat Stepniewska J, Dolegowska B, Ciechanowski K et al (2006) Erythrocyte antioxidant defense system in patients with chronic renal failure according to the hemodialysis conditions. Arch Med Res 37:353–359PubMedCrossRef Stepniewska J, Dolegowska B, Ciechanowski K et al (2006) Erythrocyte antioxidant defense system in patients with chronic renal failure according to the hemodialysis conditions. Arch Med Res 37:353–359PubMedCrossRef
12.
Zurück zum Zitat Dolegowska B, Blogowski W, Kedzierska K et al (2009) Platelets arachidonic acid metabolism in patients with essential hypertension. Platelets 20:242–249PubMedCrossRef Dolegowska B, Blogowski W, Kedzierska K et al (2009) Platelets arachidonic acid metabolism in patients with essential hypertension. Platelets 20:242–249PubMedCrossRef
13.
Zurück zum Zitat Dolegowska B, Blogowski W, Domanski L (2009) Dynamics of thromboxane level changes during early phase of allograft reperfusion. Clin Transplant 23:716–722PubMedCrossRef Dolegowska B, Blogowski W, Domanski L (2009) Dynamics of thromboxane level changes during early phase of allograft reperfusion. Clin Transplant 23:716–722PubMedCrossRef
14.
Zurück zum Zitat Dołęgowska B, Błogowski W, Domański L (2009) Is it possible to predict the early post-transplant allograft function using 20-HETE measurements? A preliminary report. Transpl Int 22:546–553PubMedCrossRef Dołęgowska B, Błogowski W, Domański L (2009) Is it possible to predict the early post-transplant allograft function using 20-HETE measurements? A preliminary report. Transpl Int 22:546–553PubMedCrossRef
15.
Zurück zum Zitat Dołęgowska B, Błogowski W, Domański L (2010) Clinical evidence of the association between serum perioperative changes in xanthine metabolizing enzymes activity and early post-transplant kidney allograft function. J Am Coll Surg 211:587–595PubMedCrossRef Dołęgowska B, Błogowski W, Domański L (2010) Clinical evidence of the association between serum perioperative changes in xanthine metabolizing enzymes activity and early post-transplant kidney allograft function. J Am Coll Surg 211:587–595PubMedCrossRef
16.
Zurück zum Zitat Mallat Z, Nakamura T, Ohan J et al (1999) The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes and plaque instability in human carotid atherosclerosis. J Clin Invest 103:421–427PubMedCrossRef Mallat Z, Nakamura T, Ohan J et al (1999) The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes and plaque instability in human carotid atherosclerosis. J Clin Invest 103:421–427PubMedCrossRef
17.
Zurück zum Zitat Kuhn H, Heydeck D, Hugou I et al (1997) In vivo action of 15-lipoxygenase in early stages of human atherogenesis. J Clin Invest 99:888–893PubMedCrossRef Kuhn H, Heydeck D, Hugou I et al (1997) In vivo action of 15-lipoxygenase in early stages of human atherogenesis. J Clin Invest 99:888–893PubMedCrossRef
18.
Zurück zum Zitat Shen J, Herderick E, Cornhill JF et al (1996) Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. J Clin Invest 98:2201–2208PubMedCrossRef Shen J, Herderick E, Cornhill JF et al (1996) Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. J Clin Invest 98:2201–2208PubMedCrossRef
19.
Zurück zum Zitat Miller LM, Sood MM, Sood AR et al (2010) Cardiovascular disease in end-stage renal disease: the challenge of assessing and managing cardiac disease in dialysis patients. Int Urol Nephrol 42:1007–1014PubMedCrossRef Miller LM, Sood MM, Sood AR et al (2010) Cardiovascular disease in end-stage renal disease: the challenge of assessing and managing cardiac disease in dialysis patients. Int Urol Nephrol 42:1007–1014PubMedCrossRef
20.
Zurück zum Zitat Paraskevas KI, Kotsikoris I, Koupidis SA, Tzovaras AA, Mikhailidis DP (2010) Cardiovascular events in chronic dialysis patients: emphasizing the importance of vascular disease prevention. Int Urol Nephrol 42:999–1006PubMedCrossRef Paraskevas KI, Kotsikoris I, Koupidis SA, Tzovaras AA, Mikhailidis DP (2010) Cardiovascular events in chronic dialysis patients: emphasizing the importance of vascular disease prevention. Int Urol Nephrol 42:999–1006PubMedCrossRef
21.
Zurück zum Zitat Wittwer J, Hersberger M (2007) The two faces of the 15-lipoxygenase in atherosclerosis. Prostaglandins Leukot Essent Fatty Acids 77:67–77PubMedCrossRef Wittwer J, Hersberger M (2007) The two faces of the 15-lipoxygenase in atherosclerosis. Prostaglandins Leukot Essent Fatty Acids 77:67–77PubMedCrossRef
22.
Zurück zum Zitat Hase H, Joki N, Ishikawa H et al (2006) Independent risk factors for progression of coronary atherosclerosis in hemodialysis patients. Ther Apher Dial 10:321–327PubMedCrossRef Hase H, Joki N, Ishikawa H et al (2006) Independent risk factors for progression of coronary atherosclerosis in hemodialysis patients. Ther Apher Dial 10:321–327PubMedCrossRef
Metadaten
Titel
Presence of glucose in dialyzing fluid and synthesis of selected lipoxygenase-derived eicosanoids during hemodialysis
verfasst von
Barbara Dołęgowska
Wojciech Błogowski
Joanna Stępniewska
Krzysztof Safranow
Katarzyna Jakubowska
Maria Olszewska
Publikationsdatum
01.12.2012
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 6/2012
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-011-0089-5

Weitere Artikel der Ausgabe 6/2012

International Urology and Nephrology 6/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.